<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 20 Jul 2026 06:03:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  EFFECT     Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Nexentis+Technologies++++++++++++++++/26786524.html</link>
   <description>si-local-file:///var/storage/secattach/20260720/26786524.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Nexentis+Technologies++++++++++++++++/26786524.html</guid>
   <pubDate>Mon, 20 Jul 2026 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  EFFECT     Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Nexentis+Technologies++++++++++++++++/26786524.html</link>
   <description>si-local-file:///var/storage/secattach/20260720/26786524.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Nexentis+Technologies++++++++++++++++/26786524.html</guid>
   <pubDate>Mon, 20 Jul 2026 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  EFFECT     Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Nexentis+Technologies++++++++++++++++/26776037.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26776037.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Nexentis+Technologies++++++++++++++++/26776037.html</guid>
   <pubDate>Thu, 16 Jul 2026 06:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  EFFECT     Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Nexentis+Technologies++++++++++++++++/26776037.html</link>
   <description>si-local-file:///var/storage/secattach/20260716/26776037.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Nexentis+Technologies++++++++++++++++/26776037.html</guid>
   <pubDate>Thu, 16 Jul 2026 06:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Nexentis Technologies                  Filed by: Lee Eun Young</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nexentis+Technologies++++++++++++++++++Filed+by%3A+Lee+Eun+Young/26773533.html</link>
   <description>si-local-file:///var/storage/secattach/20260715/26773533.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nexentis+Technologies++++++++++++++++++Filed+by%3A+Lee+Eun+Young/26773533.html</guid>
   <pubDate>Wed, 15 Jul 2026 13:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Nexentis Technologies                  Filed by: Lee Eun Young</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nexentis+Technologies++++++++++++++++++Filed+by%3A+Lee+Eun+Young/26773533.html</link>
   <description>si-local-file:///var/storage/secattach/20260715/26773533.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Nexentis+Technologies++++++++++++++++++Filed+by%3A+Lee+Eun+Young/26773533.html</guid>
   <pubDate>Wed, 15 Jul 2026 13:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Nexentis Technologies (NXTS) files for 2.57M share offering by selling stockholders</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Nexentis+Technologies+%28NXTS%29+files+for+2.57M+share+offering+by+selling+stockholders/26762536.html</link>
   <description>&lt;p&gt;Nexentis Technologies (NASDAQ: NXTS) has filed for up to 2,572,874 share offering by selling stockholders.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Nexentis+Technologies+%28NXTS%29+files+for+2.57M+share+offering+by+selling+stockholders/26762536.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:08:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis Technologies (NXTS) files for 2.57M share offering by selling stockholders</title>
   <link>http://www.streetinsider.com/Corporate+News/Nexentis+Technologies+%28NXTS%29+files+for+2.57M+share+offering+by+selling+stockholders/26762536.html</link>
   <description>&lt;p&gt;Nexentis Technologies (NASDAQ: NXTS) has filed for up to 2,572,874 share offering by selling stockholders.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Nexentis+Technologies+%28NXTS%29+files+for+2.57M+share+offering+by+selling+stockholders/26762536.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:08:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Form  S-1        Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++Nexentis+Technologies++++++++++++++++/26762507.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26762507.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++Nexentis+Technologies++++++++++++++++/26762507.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  S-1        Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++Nexentis+Technologies++++++++++++++++/26762507.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26762507.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-1++++++++Nexentis+Technologies++++++++++++++++/26762507.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  POS AM     Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Nexentis+Technologies++++++++++++++++/26762495.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26762495.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Nexentis+Technologies++++++++++++++++/26762495.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  POS AM     Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Nexentis+Technologies++++++++++++++++/26762495.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26762495.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Nexentis+Technologies++++++++++++++++/26762495.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative</title>
   <link>http://www.streetinsider.com/Press+Releases/Nexentis+Subsidiary+MitoCareX+Bio+Advances+SLC+Transporter+Drug+Discovery+with+Broad+Analysis+and+International+AI+Initiative/26739065.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;i&gt;MitoCareX Bio completes comprehensive SLC transport protein analysis to support discovery of small molecules for hard-to-treat cancers and inflammatory metabolic diseases and enters an AI-driven small-molecule discovery initiative with Boltz&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Ness Ziona, Israel, July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=WZhDZrQbnnEq3NXAYsvnB5Xfdmw-VN3h8qDv6zB7I0m83RDL70AcDUQyWQO0xS4h_YzKE3fh4mNTZ3xFB75NwzrVtk4x4SDwQmt5UjAkBsQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Nexentis Technologies Inc.&lt;/a&gt; (“Nexentis”), (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, has recently reported that its wholly owned subsidiary,&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=9N7CbRRJv13qPKYbn94K3wliRhZMoZG0SbhEPXjracy9szE6zPDkZPNU3PeL7s1pbf8gp-qmDEaE33Bl2-Roj3j9qrdT1RuqhUdcxEp6bwk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt; MitoCareX Bio Ltd.&lt;/a&gt; (“MitoCareX Bio”), successfully completed a broad analysis of SLC</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nexentis+Subsidiary+MitoCareX+Bio+Advances+SLC+Transporter+Drug+Discovery+with+Broad+Analysis+and+International+AI+Initiative/26739065.html</guid>
   <pubDate>Tue, 07 Jul 2026 08:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative</title>
   <link>http://www.streetinsider.com/Press+Releases/Nexentis+Subsidiary+MitoCareX+Bio+Advances+SLC+Transporter+Drug+Discovery+with+Broad+Analysis+and+International+AI+Initiative/26739065.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;i&gt;MitoCareX Bio completes comprehensive SLC transport protein analysis to support discovery of small molecules for hard-to-treat cancers and inflammatory metabolic diseases and enters an AI-driven small-molecule discovery initiative with Boltz&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Ness Ziona, Israel, July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=WZhDZrQbnnEq3NXAYsvnB5Xfdmw-VN3h8qDv6zB7I0m83RDL70AcDUQyWQO0xS4h_YzKE3fh4mNTZ3xFB75NwzrVtk4x4SDwQmt5UjAkBsQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Nexentis Technologies Inc.&lt;/a&gt; (“Nexentis”), (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, has recently reported that its wholly owned subsidiary,&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=9N7CbRRJv13qPKYbn94K3wliRhZMoZG0SbhEPXjracy9szE6zPDkZPNU3PeL7s1pbf8gp-qmDEaE33Bl2-Roj3j9qrdT1RuqhUdcxEp6bwk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt; MitoCareX Bio Ltd.&lt;/a&gt; (“MitoCareX Bio”), successfully completed a broad analysis of SLC</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nexentis+Subsidiary+MitoCareX+Bio+Advances+SLC+Transporter+Drug+Discovery+with+Broad+Analysis+and+International+AI+Initiative/26739065.html</guid>
   <pubDate>Tue, 07 Jul 2026 08:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nexentis+Subsidiary+MitoCareX+Bio+Advances+SLC+Transporter+Drug+Discovery+with+Broad+Analysis+and+International+AI+Initiative/26739065.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;i&gt;MitoCareX Bio completes comprehensive SLC transport protein analysis to support discovery of small molecules for hard-to-treat cancers and inflammatory metabolic diseases and enters an AI-driven small-molecule discovery initiative with Boltz&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Ness Ziona, Israel, July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=WZhDZrQbnnEq3NXAYsvnB5Xfdmw-VN3h8qDv6zB7I0m83RDL70AcDUQyWQO0xS4h_YzKE3fh4mNTZ3xFB75NwzrVtk4x4SDwQmt5UjAkBsQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Nexentis Technologies Inc.&lt;/a&gt; (“Nexentis”), (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, has recently reported that its wholly owned subsidiary,&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=9N7CbRRJv13qPKYbn94K3wliRhZMoZG0SbhEPXjracy9szE6zPDkZPNU3PeL7s1pbf8gp-qmDEaE33Bl2-Roj3j9qrdT1RuqhUdcxEp6bwk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt; MitoCareX Bio Ltd.&lt;/a&gt; (“MitoCareX Bio”), successfully completed a broad analysis of SLC</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nexentis+Subsidiary+MitoCareX+Bio+Advances+SLC+Transporter+Drug+Discovery+with+Broad+Analysis+and+International+AI+Initiative/26739065.html</guid>
   <pubDate>Tue, 07 Jul 2026 08:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nexentis+Subsidiary+MitoCareX+Bio+Advances+SLC+Transporter+Drug+Discovery+with+Broad+Analysis+and+International+AI+Initiative/26739065.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;i&gt;MitoCareX Bio completes comprehensive SLC transport protein analysis to support discovery of small molecules for hard-to-treat cancers and inflammatory metabolic diseases and enters an AI-driven small-molecule discovery initiative with Boltz&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Ness Ziona, Israel, July  07, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=WZhDZrQbnnEq3NXAYsvnB5Xfdmw-VN3h8qDv6zB7I0m83RDL70AcDUQyWQO0xS4h_YzKE3fh4mNTZ3xFB75NwzrVtk4x4SDwQmt5UjAkBsQ=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Nexentis Technologies Inc.&lt;/a&gt; (“Nexentis”), (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, has recently reported that its wholly owned subsidiary,&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=9N7CbRRJv13qPKYbn94K3wliRhZMoZG0SbhEPXjracy9szE6zPDkZPNU3PeL7s1pbf8gp-qmDEaE33Bl2-Roj3j9qrdT1RuqhUdcxEp6bwk=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt; MitoCareX Bio Ltd.&lt;/a&gt; (“MitoCareX Bio”), successfully completed a broad analysis of SLC</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nexentis+Subsidiary+MitoCareX+Bio+Advances+SLC+Transporter+Drug+Discovery+with+Broad+Analysis+and+International+AI+Initiative/26739065.html</guid>
   <pubDate>Tue, 07 Jul 2026 08:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis partially monetizes Melz solar project at $14.5M valuation</title>
   <link>http://www.streetinsider.com/Corporate+News/Nexentis+partially+monetizes+Melz+solar+project+at+%2414.5M+valuation/26702494.html</link>
   <description>&lt;p&gt;Nexentis Technologies Inc. (NASDAQ: NXTS) has signed an addendum to its Loan and Partnership Agreement related to the Melz solar photovoltaic project in Germany, resulting in a partial monetization of its investment at a total project valuation of $14.5 million, or $120,000 per megawatt.&lt;/p&gt;&lt;p&gt;The addendum was executed alongside Solterra Renewable Energy Ltd. and other lenders, following a share purchase agreement under which Solterra and its assets are being sold to Sunflower Sustainable Investments Ltd. As part of the transaction, Solterra is making early partial loan repayments.&lt;/p&gt;&lt;p&gt;Under the terms of the addendum, Nexentis will receive an early loan repayment of approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Nexentis+partially+monetizes+Melz+solar+project+at+%2414.5M+valuation/26702494.html</guid>
   <pubDate>Mon, 29 Jun 2026 08:20:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment</title>
   <link>http://www.streetinsider.com/Press+Releases/Nexentis+Announces+Monetization+of+Part+of+its+Melz+Solar+Investment+at+%2414.5+Million+Project+Valuation+%E2%80%93+Significant+Premium+to+Initial+Investment/26702491.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Neve Yarak, Israel, June  29, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=lEYNX5X9vzdYLeZc9zp7gyqsk2XVFa2PzBhd_ZA7iJyH63NSkgQs5C82qTZSNm2lfvSYWm57AsLAIsX7SxyIkiH--Zh34qcM11M06QzfCTM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;Nexentis Technologies&lt;/u&gt;&lt;/a&gt; Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today announced the signing of an Addendum to the Loan and Partnership Agreement, together with Solterra Renewable Energy Ltd. (“Solterra”) and the other lenders, for its Melz solar PV project in Germany.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Addendum follows a share purchase agreement under which Solterra and its assets are being sold to Sunflower Sustainable Investments Ltd. As</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nexentis+Announces+Monetization+of+Part+of+its+Melz+Solar+Investment+at+%2414.5+Million+Project+Valuation+%E2%80%93+Significant+Premium+to+Initial+Investment/26702491.html</guid>
   <pubDate>Mon, 29 Jun 2026 08:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment</title>
   <link>http://www.streetinsider.com/Press+Releases/Nexentis+Announces+Monetization+of+Part+of+its+Melz+Solar+Investment+at+%2414.5+Million+Project+Valuation+%E2%80%93+Significant+Premium+to+Initial+Investment/26702491.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Neve Yarak, Israel, June  29, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=lEYNX5X9vzdYLeZc9zp7gyqsk2XVFa2PzBhd_ZA7iJyH63NSkgQs5C82qTZSNm2lfvSYWm57AsLAIsX7SxyIkiH--Zh34qcM11M06QzfCTM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;Nexentis Technologies&lt;/u&gt;&lt;/a&gt; Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today announced the signing of an Addendum to the Loan and Partnership Agreement, together with Solterra Renewable Energy Ltd. (“Solterra”) and the other lenders, for its Melz solar PV project in Germany.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Addendum follows a share purchase agreement under which Solterra and its assets are being sold to Sunflower Sustainable Investments Ltd. As</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nexentis+Announces+Monetization+of+Part+of+its+Melz+Solar+Investment+at+%2414.5+Million+Project+Valuation+%E2%80%93+Significant+Premium+to+Initial+Investment/26702491.html</guid>
   <pubDate>Mon, 29 Jun 2026 08:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nexentis+Announces+Monetization+of+Part+of+its+Melz+Solar+Investment+at+%2414.5+Million+Project+Valuation+%E2%80%93+Significant+Premium+to+Initial+Investment/26702491.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Neve Yarak, Israel, June  29, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=lEYNX5X9vzdYLeZc9zp7gyqsk2XVFa2PzBhd_ZA7iJyH63NSkgQs5C82qTZSNm2lfvSYWm57AsLAIsX7SxyIkiH--Zh34qcM11M06QzfCTM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;Nexentis Technologies&lt;/u&gt;&lt;/a&gt; Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today announced the signing of an Addendum to the Loan and Partnership Agreement, together with Solterra Renewable Energy Ltd. (“Solterra”) and the other lenders, for its Melz solar PV project in Germany.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Addendum follows a share purchase agreement under which Solterra and its assets are being sold to Sunflower Sustainable Investments Ltd. As</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nexentis+Announces+Monetization+of+Part+of+its+Melz+Solar+Investment+at+%2414.5+Million+Project+Valuation+%E2%80%93+Significant+Premium+to+Initial+Investment/26702491.html</guid>
   <pubDate>Mon, 29 Jun 2026 08:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Nexentis+Announces+Monetization+of+Part+of+its+Melz+Solar+Investment+at+%2414.5+Million+Project+Valuation+%E2%80%93+Significant+Premium+to+Initial+Investment/26702491.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Neve Yarak, Israel, June  29, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=lEYNX5X9vzdYLeZc9zp7gyqsk2XVFa2PzBhd_ZA7iJyH63NSkgQs5C82qTZSNm2lfvSYWm57AsLAIsX7SxyIkiH--Zh34qcM11M06QzfCTM=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;Nexentis Technologies&lt;/u&gt;&lt;/a&gt; Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today announced the signing of an Addendum to the Loan and Partnership Agreement, together with Solterra Renewable Energy Ltd. (“Solterra”) and the other lenders, for its Melz solar PV project in Germany.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The Addendum follows a share purchase agreement under which Solterra and its assets are being sold to Sunflower Sustainable Investments Ltd. As</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Nexentis+Announces+Monetization+of+Part+of+its+Melz+Solar+Investment+at+%2414.5+Million+Project+Valuation+%E2%80%93+Significant+Premium+to+Initial+Investment/26702491.html</guid>
   <pubDate>Mon, 29 Jun 2026 08:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	  </item>
  <item>
   <title>Form  424B5      Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Nexentis+Technologies++++++++++++++++/26677462.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26677462.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Nexentis+Technologies++++++++++++++++/26677462.html</guid>
   <pubDate>Tue, 23 Jun 2026 10:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  424B5      Nexentis Technologies                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Nexentis+Technologies++++++++++++++++/26677462.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26677462.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Nexentis+Technologies++++++++++++++++/26677462.html</guid>
   <pubDate>Tue, 23 Jun 2026 10:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  8-K        Nexentis Technologies     For: Jun 22</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nexentis+Technologies+++++For%3A+Jun+22/26673840.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26673840.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nexentis+Technologies+++++For%3A+Jun+22/26673840.html</guid>
   <pubDate>Mon, 22 Jun 2026 16:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
  <item>
   <title>Form  8-K        Nexentis Technologies     For: Jun 22</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nexentis+Technologies+++++For%3A+Jun+22/26673840.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26673840.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nexentis+Technologies+++++For%3A+Jun+22/26673840.html</guid>
   <pubDate>Mon, 22 Jun 2026 16:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">NXTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08047001</category>
   	  </item>
 </channel>
</rss>
